Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Challenges for Drug Development: Cytokines, Genes, and Stem Cells.
Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis.
Is it useful to perform carbon monoxide diffusion capacity and respiratory muscle function tests in patients with multiple sclerosis without disability?
Sequencing analysis of the human glucocorticoid receptor (NR3C1) gene in multiple sclerosis patients.
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex.
In the coming year we should abandon interferons and glatiramer acetate as first-line therapy for MS: Yes.
Mechanisms of Immune Modulation By Mesenchymal Stromal Cells and Clinical Translation.
Risk Factors for Multiple Sclerosis in Kuwait: A Population-Based Case-Control Study.
Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis.
Advancing therapeutic options in multiple sclerosis with neuroprotective properties.
Extended interval dosing of natalizumab: a two-center, 7-year experience.
Is anemia a probable cause of fatigue in patients with multiple sclerosis?
Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study.
Resting State Brain Entropy Alterations in Relapsing Remitting Multiple Sclerosis.
Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.
CD226 Gly307Ser Association With Neuromyelitis Optica in Southern Han Chinese.
Multiple sclerosis: Interaction between IFN-β and vitamin D in modulation of MS risk.
Peripheral tolerance and autoimmunity: lessons from in vivo imaging.
Mobility and cognitive correlates of dual task cost of walking in persons with multiple sclerosis.
Application of the fuzzy logic concept in the multiple sclerosis functional composite for scoring the progress of multiple sclerosis.
Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis.
SIRT1 Deficiency in Microglia Contributes to Cognitive Decline in Aging and Neurodegeneration via Epigenetic Regulation of IL-1β.
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.
JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment.

Pages